Why we now use a race-free algorithm to predict kidney disease

Media Contact

Cleveland Clinic News Service 216.444.0141

Crystal Gadegbeku, M.D.

In a cleveland.com op-ed, Crystal Gadegbeku, M.D. — chair of the Department of Kidney Medicine in the Glickman Urological and Kidney Institute at Cleveland Clinic — explains the importance of not using race as a biomarker in determining a person’s kidney function.

“Because of the inherent bias in using race as a factor,” she writes, “the National Kidney Foundation and the American Society of Nephrology led a task force to find a better equation that estimates kidney function without a race variable.”

To read the complete op-ed, visit cleveland.com.